Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The "Global Continuous Subcutaneous Insulin Infusion Market (2022-2027) by Products, Patient Type, End-Uses, and Geography, Competitive Analysis and the ...

Please provide your email address to receive an email when new articles are posted on . Adults with type 1 diabetes reported improved quality of life and glycemic control when using a continuous ...

Continuous subcutaneous insulin infusion (CSII) has become an indispensable modality in the management of type 1 diabetes. This therapy employs an insulin pump to deliver both basal and bolus doses, ...

SAN FRANCISCO, July 30, 2020 /PRNewswire/ -- The global continuous subcutaneous insulin infusion market size is expected to reach USD 7.3 billion by 2027, registering a CAGR of10.3% over the forecast ...

Units for reporting HbA1c have changed from % to mmol/mol since this guidance was published. Continuous subcutaneous insulin infusion (CSII or 'insulin pump') therapy is recommended as a treatment ...

Managing diabetes can be challenging, but technology has made it significantly easier for many people. One such technological advancement is the insulin pump, a device that delivers insulin ...

Patients with type 2 diabetes who were initially treated with multiple daily injections were assessed before and after switching to continuous subcutaneous insulin infusion. OPT2MISE was a multicenter ...

After implementation of the new NICU insulin infusion guidelines, retrospective hospital chart reviews were completed for an additional 10 patients admitted to the NICU from May to August 2006. These ...

The experiments reported below concern the effect of a continuous infusion of glucose on the hepatic glucose-6-phosphatase level in rats with different levels of endogenous insulin production and ...